View in EDS HTML Full Text PDF Full Text

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.

Saved in:
Bibliographic Details
Title: IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Authors: Libura, Marta1 marta.libura@gmail.com, Bialopiotrowicz, Emilia2, Giebel, Sebastian3, Wierzbowska, Agnieszka4, Roboz, Gail J.5,6, Piatkowska-Jakubas, Beata7, Pawelczyk, Marta1, Gorniak, Patryk2, Borg, Katarzyna2, Wojtas, Magdalena2, Florek, Izabella7, Matiakowska, Karolina8, Jazwiec, Bozena9, Solarska, Iwona2, Noyszewska-Kania, Monika2, Piechna, Karolina2, Zawada, Magdalena7, Czekalska, Sylwia7, Salamanczuk, Zoriana10, Karabin, Karolina1
Source: Scientific Reports. 5/11/2021, Vol. 11 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-021-88120-y